JP2025509969A5 - - Google Patents
Info
- Publication number
- JP2025509969A5 JP2025509969A5 JP2024556148A JP2024556148A JP2025509969A5 JP 2025509969 A5 JP2025509969 A5 JP 2025509969A5 JP 2024556148 A JP2024556148 A JP 2024556148A JP 2024556148 A JP2024556148 A JP 2024556148A JP 2025509969 A5 JP2025509969 A5 JP 2025509969A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323221P | 2022-03-24 | 2022-03-24 | |
| US63/323,221 | 2022-03-24 | ||
| PCT/US2023/064908 WO2023183905A2 (en) | 2022-03-24 | 2023-03-24 | Deuterated analogs of pyrrole inhibitors of erk, synthesis thereof and intermediates thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509969A JP2025509969A (ja) | 2025-04-11 |
| JP2025509969A5 true JP2025509969A5 (enExample) | 2026-04-01 |
Family
ID=88102044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556148A Pending JP2025509969A (ja) | 2022-03-24 | 2023-03-24 | Ｅｒｋのピロール阻害剤の重水素化アナログ、その合成およびその中間体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250026733A1 (enExample) |
| EP (1) | EP4499623A2 (enExample) |
| JP (1) | JP2025509969A (enExample) |
| CN (1) | CN119212985A (enExample) |
| AU (1) | AU2023238106A1 (enExample) |
| CA (1) | CA3245978A1 (enExample) |
| IL (1) | IL315702A (enExample) |
| MX (1) | MX2024011415A (enExample) |
| TW (1) | TW202400572A (enExample) |
| WO (1) | WO2023183905A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025250391A1 (en) * | 2024-05-28 | 2025-12-04 | Biomed Valley Discoveries, Inc. | Compositions and methods for solid forms of ulixertinib |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA84930C2 (ru) * | 2004-05-14 | 2008-12-10 | Вертекс Фармасьютикалс Инкорпорейтед | Пиррольные соединения как ингибиторы протеинкиназ erk, их синтез и соответствующие промежуточные соединения |
| US9227969B2 (en) * | 2013-08-14 | 2016-01-05 | Novartis Ag | Compounds and compositions as inhibitors of MEK |
| HK1244274A1 (zh) * | 2015-01-30 | 2018-08-03 | 生物医学谷探索股份有限公司 | C21h22ci2n4o2的晶型 |
-
2023
- 2023-03-24 WO PCT/US2023/064908 patent/WO2023183905A2/en not_active Ceased
- 2023-03-24 CA CA3245978A patent/CA3245978A1/en active Pending
- 2023-03-24 AU AU2023238106A patent/AU2023238106A1/en active Pending
- 2023-03-24 MX MX2024011415A patent/MX2024011415A/es unknown
- 2023-03-24 EP EP23775913.9A patent/EP4499623A2/en active Pending
- 2023-03-24 CN CN202380038832.XA patent/CN119212985A/zh active Pending
- 2023-03-24 TW TW112111234A patent/TW202400572A/zh unknown
- 2023-03-24 JP JP2024556148A patent/JP2025509969A/ja active Pending
- 2023-03-24 IL IL315702A patent/IL315702A/en unknown
-
2024
- 2024-09-23 US US18/893,686 patent/US20250026733A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010507585A5 (enExample) | ||
| JP2012503010A5 (enExample) | ||
| JP2012524085A5 (enExample) | ||
| JP2009511481A5 (enExample) | ||
| JP2009538359A5 (enExample) | ||
| JP2009539863A5 (enExample) | ||
| US11191757B2 (en) | Combination of pimavanserin and cytochrome P450 modulators | |
| ES2693948T3 (es) | Fenetilamina sustituida con actividad serotoninérgica y/o norepinefrinérgica | |
| US20080280886A1 (en) | Substituted ureas | |
| KR20160117596A (ko) | 신규 제약 제제 | |
| JP2010512343A5 (enExample) | ||
| AU2008245662A1 (en) | Deuterium labelled ketamine | |
| JP2016529228A5 (enExample) | ||
| US10953000B2 (en) | Combination of pimavanserin and cytochrome P450 modulators | |
| TW201636336A (zh) | 經氘取代的二唑 | |
| US20110082151A1 (en) | Sulfonylurea modulators of endothelin receptor | |
| CA2690379A1 (en) | Substituted piperazines | |
| CA2631581A1 (en) | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity | |
| JP2025509969A5 (enExample) | ||
| AU2007286186A1 (en) | Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects | |
| US20100075950A1 (en) | Phenylpropanone modulators of dopamine receptor | |
| JP2018507210A5 (enExample) | ||
| US20100286124A1 (en) | Prop-2-yn-1-amine inhibitors of monoamine oxidase type b | |
| CN110612286A (zh) | 氰基取代的稠合双环衍生物及其制备方法和用途 | |
| RU2024129873A (ru) | Дейтерированные аналоги пиррольных ингибиторов erk, их синтез и промежуточные соединения |